Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

Basit Öğe Kaydı
dc.authoridBahçecioğlu, Ömer Faruk/0000-0002-4045-4555
dc.authoridDurmus, Mefkure/0000-0001-9745-4196
dc.authoridSARICI, Ahmet/0000-0002-5916-0119
dc.authoridGOK, Selim/0000-0003-3179-1899
dc.authorwosidBahçecioğlu, Ömer Faruk/AAA-7477-2021
dc.authorwosidDurmus, Mefkure/ISR-9328-2023
dc.authorwosidSARICI, Ahmet/ABI-7512-2020
dc.contributor.authorBahcecioglu, Omer Faruk
dc.contributor.authorGok, Selim
dc.contributor.authorDurmus, Mefkure
dc.contributor.authorSarici, Ahmet
dc.date.accessioned2024-08-04T20:50:48Z
dc.date.available2024-08-04T20:50:48Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.htct.2021.06.005
dc.identifier.endpage528en_US
dc.identifier.issn2531-1379
dc.identifier.issue4en_US
dc.identifier.pmid34456173en_US
dc.identifier.scopus2-s2.0-85118486473en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage527en_US
dc.identifier.urihttps://doi.org/10.1016/j.htct.2021.06.005
dc.identifier.urihttps://hdl.handle.net/11616/100294
dc.identifier.volume43en_US
dc.identifier.wosWOS:000714978700023en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofHematology Transfusion and Cell Therapyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectConditioning Regimensen_US
dc.subjectBuen_US
dc.subjectCyen_US
dc.titleIs there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu